Services



Nutraceutical Products



Search Knowledge Base



TeleClasses & Events




The Cancer Coach



Subscribe to
     Morph2Health




Home
    
Dr. James partners with persons with cancers and other serious illnesses to construct a "whole person" roadmap leading to health and well-being. To immediately receive a free copy of my groundbreaking book, Conquer Your Fear of Cancer, click here now to sign up for a free homepage.




Behavioral Oncology Definitions -> Autologous Communications: The Autocrine/Paracrine Languages -> Granuloctye-macrophage colony-stimulating factor as an autocrine survival factor for mature normal and malignant B lymphocytes.

Granuloctye-macrophage colony-stimulating factor as an autocrine survival factor for mature normal and malignant B lymphocytes.

The role of GM-CSF in B cell (patho)physiology is unclear. Although B cells can respond to GM-CSF, there is controversy concerning the extent to which various resting and activated B cell types can themselves produce this cytokine, and the possibility that it can function in an autocrine fashion has not previously been considered. The aim of the present study was to address these issues using hairy cells (HCs) and chronic lymphocytic leukemia cells, two intrinsically activated mature malignant B cell types (with activation being more uniform and more pronounced in HCs). Normal B cells were used for comparison. Using a number of techniques, we demonstrated the constitutive production of GM-CSF by all three cell types and showed that the cytokine was biologically active. GM-CSF mRNA and protein were increased after cell activation by PMA, and constitutive production of the cytokine was highest in HCs, suggesting that the level of GM-CSF production is influenced by cell activation. Because GM-CSF is known to be antiapoptotic for myeloid cells, we used blocking anti-GM-CSF Abs to examine the contribution of autocrinely produced cytokine to cell survival. The Abs produced marked reduction in the in vitro survival of HCs, chronic lymphocytic leukemia cells, and normal B cells by promoting apoptosis. Taken together, these findings suggest that, in combination with other known rescue factors, autocrinely produced GM-CSF may contribute to normal and malignant B cell survival in vivo.

Harris RJ, Pettitt AR, Schmutz C, Sherrington PD, Zuzel M, Cawley JC, Griffiths SD.

Department of Haematology, University of Liverpool, Liverpool, United Kingdom. harris@liv.ac.uk

Granulocyte-macrophage colony-stimulating factor as an autocrine survival factor for mature normal and malignant B lymphocytes



Homepage | About ATO | Contact ATO | Privacy Policy | Terms and Conditions
Send Questions or Comments to info@james-arond-thomas.com
Contact Dr. James Today: (734) 973-8700.

© 2001-2006 James A. Arond-Thomas, M.D. All Rights Reserved. This content may be copied in full, with copyright, contact, creation and information intact, without specific permission, when used only in a not-for-profit format. If any other use is desired, permission in writing from Dr. Arond-Thomas is required.

Disclaimer: The entire contents of this website are based upon the opinions of Dr. Arond-Thomas, unless otherwise noted. Individual articles are based upon the opinions of the respective author, who retains copyright as marked. The information on this website is not intended to replace a one-on-one relationship with a qualified health care professional and is not intended as medical advice. It is intended as a sharing of knowledge and information from the research and experience of Dr. Arond-Thomas and his community. Dr. Arond-Thomas encourages you to make your own health care decisions based upon your research and in partnership with a qualified health care professional.
Arond-Thomas Online Sitemap